Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

MSFN: a multi-omics stacked fusion network for breast cancer survival prediction

A Multimodal Affinity Fusion Network for Predicting the Survival of Breast Cancer Patients

Deep multi-modal fusion network with gated unit for breast cancer survival prediction

FGCNSurv: dually fused graph convolutional network for multi-omics survival prediction

Multimodal Survival Ensemble Network: Integrating Genomic and Histopathological Insights for Enhanced Cancer Prognosis.

TTMFN: Two-stream Transformer-based Multimodal Fusion Network for Survival Prediction

Predicting the Survival of Cancer Patients With Multimodal Graph Neural Network

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration

M2EF-NNs: Multimodal Multi-instance Evidence Fusion Neural Networks for Cancer Survival Prediction

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study

Survival Prediction for Non-Small Cell Lung Cancer Based on Multimodal Fusion and Deep Learning

Integration of multi-omics data for survival prediction of lung adenocarcinoma

Self-supervised learning-based Multi-Scale feature Fusion Network for survival analysis from whole slide images

DCCAFN: deep convolution cascade attention fusion network based on imaging genomics for prediction survival analysis of lung cancer

Quantifying the advantage of multimodal data fusion for survival prediction in cancer patients

Stacked Autoencoder Based Multi-Omics Data Integration for Cancer Survival Prediction

Cross-modality Attention-based Multimodal Fusion for Non-small Cell Lung Cancer (NSCLC) Patient Survival Prediction

BioFusionNet: Deep Learning-Based Survival Risk Stratification in ER+ Breast Cancer Through Multifeature and Multimodal Data Fusion

A Cancer Survival Prediction Method Based on Graph Convolutional Network